Medulloblastoma is the most common form of malignant brain tumor in children, which often can be cured with operation, radiation and chemotherapy. But a distinct type of medulloblastoma has an increased risk of becoming resistant ...
Oct 28, 2022
0
10
Leukemia patients receive a bone marrow transplant, which allows them to build a "new" immune system. However, this immune system not only attacks cancer cells but healthy tissue too. Special antibodies will be used to protect ...
Apr 2, 2013
0
0
Taking the new generation anti-inflammatory drug natalizumab for two years lowers the number of remitting multiple sclerosis patients who experience relapses and progression of disability. This is the main finding of a systematic ...
Oct 5, 2011
0
0
Cancer cells in children tend to develop by following four main trajectories—and two of them are linked to relapse of the disease, according to a study led by Lund University in Sweden, now published in Nature Genetics. ...
Jun 5, 2018
0
5
City academics and students from the Centre of Psychological Wellbeing and Neuroscience are collaborating with the North East London NHS Foundation Trust to see if Mindfulness Based Cognitive Therapy (MBCT) can prevent relapse ...
Nov 13, 2015
0
29
A research team from the Faculty of Pharmacy at the University of Valencia has shown that the presence of physical pain alters the effect of alcohol as a reinforcement to avoid suffering. The study, published in journal Pain, ...
Sep 1, 2020
0
6
(Medical Xpress) -- This week the Journal of the American Medical Association published a study with unfortuate news for the millions of people who suffer from multiple sclerosis. In the large study, a therapy known as interferon ...
Jul 23, 2012
0
0
A new computational study published in the International Journal of Bioinformatics Research and Applications has shown how mutations that give rise to drug resistance occur in a form of cancer known as acute myeloid leukemia ...
Aug 4, 2015
0
7
Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL). The randomized phase 3 study E1910 evaluated blinatumomab immunotherapy in patients with ...
Dec 13, 2022
0
3
Women with multiple sclerosis (MS) who intended to breastfeed their infants exclusively for two months had a lower risk of relapse during the first six months after giving birth compared with women who did not breastfeed ...
Aug 31, 2015
0
92
